Chubb (CB) vs. Travelers (TRV): Which P&C Insurance Giant Is the Better Buy?
Chubb Limited (NYSE:CB) and The Travelers Companies, Inc. (NYSE:TRV) are two of the best property-and-casualty insurers in the world.
Insider Monkey Blog
10 Best Blue Chip Stocks Under $100 to Buy Now
Blue-chip stocks are shares of large, well-established companies with strong financial positions, leading market positions, and often long operating histories.
Jim Cramer Returns to His Favorite Gold Miner as the Outlook Shifts
During the October 8 episode of Mad Money, Jim Cramer talked about Agnico Eagle Mines Limited (NYSE:AEM) after discussing a more bullish technical outlook for gold earlier in ...
A Question About Corn Prices Brings Out Jim Cramer’s Conviction in Deere (DE)
During the October 2 episode of Mad Money, a caller noted that the price of corn is up about 20% following a couple of down years and asked Jim Cramer for his thoughts on Deere...
Jim Cramer Likes Part of the Celsius (CELH) Story but Something Is Missing
On October 8, a caller asked whether Celsius Holdings, Inc. (NASDAQ:CELH) was broken or facing an execution problem.
Jim Cramer Explains Why He Hasn’t Given Up on American Express (AXP)
During the October 8 episode of Mad Money, a caller challenged American Express Company’s (NYSE:AXP) recent performance and management’s growth promises.
Jim Cramer Makes the Case for Home Depot (HD) Before the Mood Changes
During the October 8 episode of Mad Money, Jim Cramer pointed to The Home Depot, Inc.
Jim Cramer Says ADM’s “Time Has Come” and Names Another Agricultural Favorite
During the October 7 lightning round of Mad Money, a caller highlighted Archer-Daniels-Midland Company’s (NYSE:ADM) forward earnings multiple and dividend before asking whether...
Jim Cramer Has Very Different Views on MiniMed (MMED) and Medtronic (MDT)
Starting the lightning round of Mad Money on October 7, a caller mentioned MiniMed Group, Inc. (NASDAQ:MMED).
A Question About Vertiv (VRT) Leads Jim Cramer to a Bigger Infrastructure Story
During the October 7 episode of Mad Money, a caller asked whether Jim Cramer had concerns about data center infrastructure while discussing Vertiv Holdings Co (NYSE:VRT).
A Western Digital (WDC) Investor’s Losses Prompt Jim Cramer to Bring Up Micron (MU)
During the October 7 episode of Mad Money, a caller said they had been averaging down on Western Digital Corporation (NASDAQ:WDC) but remained significantly underwater.
Jim Cramer Takes a Fresh Look at Constellation (STZ) Brands After an Unexpected Reversal
During the October 7 episode of Mad Money, Jim Cramer discussed Constellation Brands, Inc. (NYSE:STZ) after its earnings reaction took an unexpected turn.
Visa (V): Are Bigger Client Rebates Worth the Valuation?
Visa Inc. (NYSE:V) operates a global payments network, earning fees from payment volumes, transaction processing, and related services.
Hershey (HSY): Can Recovering Chocolate Profits Justify its Valuation?
The Hershey Company (NYSE:HSY) manufactures chocolate, candy, and salty snacks, selling through retailers and distributors.
Watsco (WSO): Does Its Valuation Leave Room for Weaker Profits?
Watsco, Inc. (NYSE:WSO) distributes heating, cooling, and refrigeration equipment, parts, and supplies to contractors across North America.
Is CrowdStrike (CRWD) Still Worth the Premium After 140% Surge?
CrowdStrike Holdings Inc. (NASDAQ:CRWD) is up 140% year-to-date, and the stock has outpaced the broader market by almost eight times during the 52-week stretch.
Colgate-Palmolive (CL): Can Hill’s Turn Premium Pricing Into Better Profits?
Colgate-Palmolive Company (NYSE:CL) manufactures and sells toothpaste, personal care products, household cleaners, and pet nutrition worldwide.
Nvidia (NVDA): Is Its Moderate Earnings Multiple Justified by Revenue Growth?
The main concerns around NVIDIA Corp.
10 Best Undervalued Stocks to Buy in October
In this article, we will discuss the 10 Best Undervalued Stocks to Buy in October. A low price-to-earnings ratio can tell two very different stories.
Constellation’s $4.3 Billion Nuclear Upgrade Could Be Its Smartest Move Yet
Constellation Energy Corporation (NASDAQ:CEG) shares surged 12.2% on October 6, among the S&P 500’s biggest gains that day.
Medtronic’s Modest Valuation Meets an Improving Growth Outlook
Medtronic plc (NYSE:MDT) has taken a very different path from the broader market over the past year.
Thermo Fisher Stock Trades at a Premium. Can Its Earnings Keep Up?
Thermo Fisher Scientific, Inc. (NYSE:TMO) is having a good year, with shares surging by over 11% so far.
Gilead Has Outperformed the S&P 500. But is its Valuation Still Attractive?
Gilead Sciences, Inc. (NASDAQ:GILD) has had a considerably better year than the broader market.
Johnson & Johnson Stock Has Surged 44%, Can Its Growth Justify the Valuation?
Johnson & Johnson (NYSE:JNJ) is no longer trading like a stock that investors have simply overlooked.
Pfizer Is Trading at Less Than 10 Times Earnings. But Is the Stock Actually Cheap?
Pfizer Inc. (NYSE:PFE) has barely rewarded shareholders over the past year. That underperformance has left Pfizer looking inexpensive.
Nova’s Revenue Grew 16%, but EPS Rose Just 3%. Where Did the Growth Go?
Nova Ltd. (NASDAQ:NVMI) grew second-quarter revenue 15.9%, but diluted GAAP earnings per share increased only 2.8%.
KLA Returned More Cash Than It Generated Last Quarter. Is That a Problem?
KLA Corporation (NASDAQ:KLAC) returned $876.3 million to shareholders in its fiscal fourth quarter while generating $817.1 million of free cash flow.
Lam Research’s Support Revenue Jumped 43%. How Much Protection Does It Offer?
Lam Research Corporation (NASDAQ:LRCX) reported $2.472 billion of customer support-related and other revenue in its June quarter, up from $1.734 billion a year earlier.
T. Rowe Price Stock Has Fallen Out of Favor. Could That Create an Opportunity?
T. Rowe Price Group, Inc. (NASDAQ:TROW) is an active investment manager that earns most of its revenue from management fees, which naturally ebb and flow with the markets.
ABM Industries: A Boring Dividend Stock with an Interesting Valuation
ABM Industries Incorporated (NYSE:ABM) isn’t the kind of stock that makes headlines, but for income-focused investors, it deserves a closer look.
PepsiCo Just Cut its Earnings Forecast. Is the Stock Still Worth Buying?
PepsiCo, Inc. (NASDAQ:PEP) is a familiar name for investors who want steady income.
Coca-Cola Has a Dividend Investors Love. Its Valuation is Another Story
The Coca-Cola Company (NYSE:KO) is a fixture in many dividend portfolios, and for good reason.
Is Parker Hannifin’s Premium Valuation a Warning Sign for Dividend Investors?
Parker-Hannifin Corporation (NYSE:PH) has established an extensive history of increasing its dividend by providing products that ensure that important industrial and aerospace...
Abbott Laboratories is More than a Dividend Stock. Here’s Why.
Abbott Laboratories (NYSE:ABT) offers investors access to several segments of the healthcare industry, including diabetes care, medical devices, and diagnostics.
McDonald’s Has a Powerful Brand and a Growing Dividend. Is That Enough?
McDonald's Corporation (NYSE:MCD) brings together a restaurant brand that is world-famous with a business approach relying heavily on franchises and, as a result, produces a large...
Why Income Investors May Want to Take a Closer Look at Sysco Stock
Sysco Corporation (NYSE:SYY) operates a business that most people never consider but on which they depend every day.
AMD’s Biggest Problem Is No Longer Demand. Lisa Su Is in Asia to Fix the Real One
Advanced Micro Devices Inc. (NASDAQ:AMD) CEO Lisa Su expects chip demand to stay “very high” for the next several years.
Intel and Applied Materials Just Deepened Their AI Partnership. Which Stock Looks Better Positioned?
Applied Materials Inc. (NASDAQ:AMAT) and Intel Corporation (NASDAQ:INTC) announced on October 6 that they are expanding their partnership on next-generation AI chipmaking.
7 Best Airport and Air Services Stocks to Buy
Every flight depends on a network of airports and service providers whose earnings are shaped by how efficiently they keep passengers and aircraft moving.
10 Best Biotech Stocks to Invest In According to Billionaires
The race to secure the next blockbuster medicine is giving biotech investors two opportunities to assess: the value a treatment could generate and the price a larger drugmaker...
Jim Cramer Says a Powerful Trend Is Working Against Flagstar (FLG)
During the October 8 lightning round of Mad Money, a caller asked about Flagstar Bank, National Association (NYSE:FLG).
Jim Cramer Explains Why He Isn’t Writing Off Levi Strauss (LEVI)
During the October 7 episode of Mad Money, Jim Cramer examined Levi Strauss & Co.’s (NYSE:LEVI) newly released results, as he said that investors should look beyond the mixed...
Jim Cramer Makes a Contrarian Call on Chipotle (CMG)
On October 7, a caller asked whether Chipotle Mexican Grill, Inc. (NYSE:CMG) would reach lower lows before recovering.
Veeva Systems’ (VEEV) Comeback Gets Jim Cramer Talking
During the October 7 episode of Mad Money, Jim Cramer discussed Veeva Systems Inc.
Jim Cramer Isn’t Convinced by the Rambus (RMBS) Story
During the October 7 lightning round of Mad Money, a caller asked whether Rambus Inc. (NASDAQ:RMBS) was a hold, sell, or buy.
Jim Cramer Explains How He Would Approach L3Harris (LHX)
During the October 7 lightning round of Mad Money, a caller asked whether they were “crazy” to consider starting a position in L3Harris Technologies, Inc. (NYSE:LHX).
A Longtime NetApp (NTAP) Shareholder Gets a Clear Answer From Jim Cramer
During the lightning round of the October 1 episode of Mad Money, a caller said they had held NetApp, Inc.
GigaCloud’s (GCT) Growth Story Meets Jim Cramer’s Speculation
Answering a caller’s query about GigaCloud Technology Inc.
Jim Cramer Gives Babcock & Wilcox (BW) a Chance With One Condition
Toward the end of the lightning round on October 7, a caller asked if they would be making a mistake buying Babcock & Wilcox Enterprises, Inc. (NYSE:BW) at its current level.
Hedge Fund Resource Center
